Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: Summary of a symposium

Vishnudutt Purohit, Manal F. Abdelmalek, Shirish Barve, Norlin J. Benevenga, Charles H. Halsted, Neil Kaplowitz, Kusum Kharbanda, Qi Ying Liu, Shelly C. Lu, Craig J. McClain, Christine Swanson, Samir Zakhari

Research output: Contribution to journalReview article

117 Citations (Scopus)

Abstract

This report is a summary of a symposium on the role of S-adenosylmethionine (SAM), betaine, and folate in the treatment of alcoholic liver disease (ALD), which was organized by the National Institute on Alcohol Abuse and Alcoholism in collaboration with the Office of Dietary Supplements and the National Center for Complementary and Alternative Medicine of the National Institutes of Health (Bethesda, MD) and held on 3 October 2005. SAM supplementation may attenuate ALD by decreasing oxidative stress through the up-regulation of glutathione synthesis, reducing inflammation via the down-regulation of tumor necrosis factor-α and the up-regulation of interleukin-10 synthesis, increasing the ratio of SAMto S-adenosylhomocysteine (SAH), and inhibiting the apoptosis of normal hepatocytes and stimulating the apoptosis of liver cancer cells. Folate deficiency may accelerate or promote ALD by increasing hepatic homocysteine and SAH concentrations; decreasing hepaticSAMand glutathione concentrations and the SAM-SAH ratio; increasing cytochrome P4502E1 activation and lipid peroxidation; up-regulating endoplasmic reticulum stress markers, including sterol regulatory element- binding protein-1, and proapoptotic gene caspase-12; and decreasing global DNA methylation. Betaine may attenuate ALD by increasing the synthesis of SAM and, eventually, glutathione, decreasing the hepatic concentrations of homocysteine and SAH, and increasing the SAM-SAH ratio, which can trigger a cascade of events that lead to the activation of phosphatidylethanolamine methyltransferase, increased phosphatidylcholine synthesis, and formation of VLDL for the export of triacylglycerol from the liver to the circulation. Additionally, decreased concentrations of homocysteine can down-regulate endoplasmic reticulum stress, which leads to the attenuation of apoptosis and fatty acid synthesis.

Original languageEnglish (US)
Pages (from-to)14-24
Number of pages11
JournalAmerican Journal of Clinical Nutrition
Volume86
Issue number1
StatePublished - Jul 1 2007

Fingerprint

S-Adenosylhomocysteine
S-Adenosylmethionine
Betaine
Alcoholic Liver Diseases
adenosylhomocysteine
S-adenosylmethionine
betaine
liver diseases
alcohol abuse
Folic Acid
folic acid
Homocysteine
homocysteine
Glutathione
synthesis
Endoplasmic Reticulum Stress
glutathione
Apoptosis
alternative medicine
apoptosis

Keywords

  • Alcohol
  • Betaine
  • Folate
  • Liver disease
  • S-adenosylmethionine

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Purohit, V., Abdelmalek, M. F., Barve, S., Benevenga, N. J., Halsted, C. H., Kaplowitz, N., ... Zakhari, S. (2007). Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: Summary of a symposium. American Journal of Clinical Nutrition, 86(1), 14-24.

Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease : Summary of a symposium. / Purohit, Vishnudutt; Abdelmalek, Manal F.; Barve, Shirish; Benevenga, Norlin J.; Halsted, Charles H.; Kaplowitz, Neil; Kharbanda, Kusum; Liu, Qi Ying; Lu, Shelly C.; McClain, Craig J.; Swanson, Christine; Zakhari, Samir.

In: American Journal of Clinical Nutrition, Vol. 86, No. 1, 01.07.2007, p. 14-24.

Research output: Contribution to journalReview article

Purohit, V, Abdelmalek, MF, Barve, S, Benevenga, NJ, Halsted, CH, Kaplowitz, N, Kharbanda, K, Liu, QY, Lu, SC, McClain, CJ, Swanson, C & Zakhari, S 2007, 'Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: Summary of a symposium', American Journal of Clinical Nutrition, vol. 86, no. 1, pp. 14-24.
Purohit V, Abdelmalek MF, Barve S, Benevenga NJ, Halsted CH, Kaplowitz N et al. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: Summary of a symposium. American Journal of Clinical Nutrition. 2007 Jul 1;86(1):14-24.
Purohit, Vishnudutt ; Abdelmalek, Manal F. ; Barve, Shirish ; Benevenga, Norlin J. ; Halsted, Charles H. ; Kaplowitz, Neil ; Kharbanda, Kusum ; Liu, Qi Ying ; Lu, Shelly C. ; McClain, Craig J. ; Swanson, Christine ; Zakhari, Samir. / Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease : Summary of a symposium. In: American Journal of Clinical Nutrition. 2007 ; Vol. 86, No. 1. pp. 14-24.
@article{2cf33c06165b448d9e93ff14f334a97b,
title = "Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: Summary of a symposium",
abstract = "This report is a summary of a symposium on the role of S-adenosylmethionine (SAM), betaine, and folate in the treatment of alcoholic liver disease (ALD), which was organized by the National Institute on Alcohol Abuse and Alcoholism in collaboration with the Office of Dietary Supplements and the National Center for Complementary and Alternative Medicine of the National Institutes of Health (Bethesda, MD) and held on 3 October 2005. SAM supplementation may attenuate ALD by decreasing oxidative stress through the up-regulation of glutathione synthesis, reducing inflammation via the down-regulation of tumor necrosis factor-α and the up-regulation of interleukin-10 synthesis, increasing the ratio of SAMto S-adenosylhomocysteine (SAH), and inhibiting the apoptosis of normal hepatocytes and stimulating the apoptosis of liver cancer cells. Folate deficiency may accelerate or promote ALD by increasing hepatic homocysteine and SAH concentrations; decreasing hepaticSAMand glutathione concentrations and the SAM-SAH ratio; increasing cytochrome P4502E1 activation and lipid peroxidation; up-regulating endoplasmic reticulum stress markers, including sterol regulatory element- binding protein-1, and proapoptotic gene caspase-12; and decreasing global DNA methylation. Betaine may attenuate ALD by increasing the synthesis of SAM and, eventually, glutathione, decreasing the hepatic concentrations of homocysteine and SAH, and increasing the SAM-SAH ratio, which can trigger a cascade of events that lead to the activation of phosphatidylethanolamine methyltransferase, increased phosphatidylcholine synthesis, and formation of VLDL for the export of triacylglycerol from the liver to the circulation. Additionally, decreased concentrations of homocysteine can down-regulate endoplasmic reticulum stress, which leads to the attenuation of apoptosis and fatty acid synthesis.",
keywords = "Alcohol, Betaine, Folate, Liver disease, S-adenosylmethionine",
author = "Vishnudutt Purohit and Abdelmalek, {Manal F.} and Shirish Barve and Benevenga, {Norlin J.} and Halsted, {Charles H.} and Neil Kaplowitz and Kusum Kharbanda and Liu, {Qi Ying} and Lu, {Shelly C.} and McClain, {Craig J.} and Christine Swanson and Samir Zakhari",
year = "2007",
month = "7",
day = "1",
language = "English (US)",
volume = "86",
pages = "14--24",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "1",

}

TY - JOUR

T1 - Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease

T2 - Summary of a symposium

AU - Purohit, Vishnudutt

AU - Abdelmalek, Manal F.

AU - Barve, Shirish

AU - Benevenga, Norlin J.

AU - Halsted, Charles H.

AU - Kaplowitz, Neil

AU - Kharbanda, Kusum

AU - Liu, Qi Ying

AU - Lu, Shelly C.

AU - McClain, Craig J.

AU - Swanson, Christine

AU - Zakhari, Samir

PY - 2007/7/1

Y1 - 2007/7/1

N2 - This report is a summary of a symposium on the role of S-adenosylmethionine (SAM), betaine, and folate in the treatment of alcoholic liver disease (ALD), which was organized by the National Institute on Alcohol Abuse and Alcoholism in collaboration with the Office of Dietary Supplements and the National Center for Complementary and Alternative Medicine of the National Institutes of Health (Bethesda, MD) and held on 3 October 2005. SAM supplementation may attenuate ALD by decreasing oxidative stress through the up-regulation of glutathione synthesis, reducing inflammation via the down-regulation of tumor necrosis factor-α and the up-regulation of interleukin-10 synthesis, increasing the ratio of SAMto S-adenosylhomocysteine (SAH), and inhibiting the apoptosis of normal hepatocytes and stimulating the apoptosis of liver cancer cells. Folate deficiency may accelerate or promote ALD by increasing hepatic homocysteine and SAH concentrations; decreasing hepaticSAMand glutathione concentrations and the SAM-SAH ratio; increasing cytochrome P4502E1 activation and lipid peroxidation; up-regulating endoplasmic reticulum stress markers, including sterol regulatory element- binding protein-1, and proapoptotic gene caspase-12; and decreasing global DNA methylation. Betaine may attenuate ALD by increasing the synthesis of SAM and, eventually, glutathione, decreasing the hepatic concentrations of homocysteine and SAH, and increasing the SAM-SAH ratio, which can trigger a cascade of events that lead to the activation of phosphatidylethanolamine methyltransferase, increased phosphatidylcholine synthesis, and formation of VLDL for the export of triacylglycerol from the liver to the circulation. Additionally, decreased concentrations of homocysteine can down-regulate endoplasmic reticulum stress, which leads to the attenuation of apoptosis and fatty acid synthesis.

AB - This report is a summary of a symposium on the role of S-adenosylmethionine (SAM), betaine, and folate in the treatment of alcoholic liver disease (ALD), which was organized by the National Institute on Alcohol Abuse and Alcoholism in collaboration with the Office of Dietary Supplements and the National Center for Complementary and Alternative Medicine of the National Institutes of Health (Bethesda, MD) and held on 3 October 2005. SAM supplementation may attenuate ALD by decreasing oxidative stress through the up-regulation of glutathione synthesis, reducing inflammation via the down-regulation of tumor necrosis factor-α and the up-regulation of interleukin-10 synthesis, increasing the ratio of SAMto S-adenosylhomocysteine (SAH), and inhibiting the apoptosis of normal hepatocytes and stimulating the apoptosis of liver cancer cells. Folate deficiency may accelerate or promote ALD by increasing hepatic homocysteine and SAH concentrations; decreasing hepaticSAMand glutathione concentrations and the SAM-SAH ratio; increasing cytochrome P4502E1 activation and lipid peroxidation; up-regulating endoplasmic reticulum stress markers, including sterol regulatory element- binding protein-1, and proapoptotic gene caspase-12; and decreasing global DNA methylation. Betaine may attenuate ALD by increasing the synthesis of SAM and, eventually, glutathione, decreasing the hepatic concentrations of homocysteine and SAH, and increasing the SAM-SAH ratio, which can trigger a cascade of events that lead to the activation of phosphatidylethanolamine methyltransferase, increased phosphatidylcholine synthesis, and formation of VLDL for the export of triacylglycerol from the liver to the circulation. Additionally, decreased concentrations of homocysteine can down-regulate endoplasmic reticulum stress, which leads to the attenuation of apoptosis and fatty acid synthesis.

KW - Alcohol

KW - Betaine

KW - Folate

KW - Liver disease

KW - S-adenosylmethionine

UR - http://www.scopus.com/inward/record.url?scp=34447259792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447259792&partnerID=8YFLogxK

M3 - Review article

C2 - 17616758

AN - SCOPUS:34447259792

VL - 86

SP - 14

EP - 24

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 1

ER -